United States · 
Who invested in Ouro Medicines?
Ouro Medicines's investors include New Enterprise Associates, Norwest Venture Partners and TPG.
United States · Series A startup
Who invested in Ouro Medicines
Funding summaryUpdated 26 Oct 2026
$120Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $120MJan 2025
- Investors
- 3
The rounds
- Jan 2025
Founders and team
From Ouro Medicines's own website: 9 on the team.
- Henry GosebruchExecutive Director and Chief Executive Officer
- Ruth LanVice President Research and Translation
- Aaron CoxChief Financial Officer
- Dan GrossmanChief Strategy Officer
- Eric HedrickChief Medical Officer
- Sooin KwonChief Business Officer
- Tania PhilippChief People Officer
- Fred BlakesleeGeneral Counsel
- Manage ConsentCorporate Governance Board of Directors
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ouro Medicines
How much has Ouro Medicines raised?
Ouro Medicines has raised $120M across 1 round since 2025.
When did Ouro Medicines last raise?
Ouro Medicines's most recent round was a Series A of $120M in Jan 2025.
What was Ouro Medicines's biggest round?
Its most recent round, $120M in Jan 2025, is also its largest on record.
Who backed Ouro Medicines first?
Ouro Medicines's first round on record, in Jan 2025, was backed by New Enterprise Associates, Norwest Venture Partners and TPG.
What stage is Ouro Medicines at?
Ouro Medicines's latest named round is a Series A, in Jan 2025.
Where is Ouro Medicines based?
Ouro Medicines is based in the United States.
Companies like Ouro Medicines
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.